PAVmed
PAVM
7 hedge funds and large institutions have $582K invested in PAVmed in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
40% more funds holding
Funds holding: 5 → 7 (+2)
21% more capital invested
Capital invested by funds: $481K → $582K (+$101K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$184K |
| 2 |
Goldman Sachs
New York
|
+$124K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.28K |
| 4 |
BlackRock
New York
|
+$4.14K |
| 5 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$2.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFW
Fusion Family Wealth
Woodbury,
New York
|
-$251K |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$62.1K |
PAVM Hedge Fund Activity: Q3 2017 in Review
7 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q3 2017, worth a combined $582K — up 21% from $481K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PAVM positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $184K. The largest seller was Fusion Family Wealth, exiting entirely with an estimated $251K sold.
- 7 institutional investors held PAVmed (PAVM) as of Q3 2017, up from 5 in Q2 2017.
- Funds reported $582K of PAVmed stock for Q3 2017, up 21% quarter-over-quarter.
- 3 funds opened new PAVmed positions in Q3 2017 and 1 closed out, a net change of +2 holders.
- The largest PAVmed buyer in Q3 2017 was Millennium Management, an estimated $184K added.
- The largest PAVmed seller in Q3 2017 was Fusion Family Wealth, an estimated $251K sold.
Based on aggregated 13F filings for Q3 2017.